LIPO-202

DRUG6 trials

Sponsors

Neothetics, Inc, Evofem Inc.

Conditions

Central Abdominal BulgingSubmental Fat

Phase 2

An Open-Label Study to Evaluate Retreatment With LIPO-202

Neothetics, IncCentral Abdominal Bulging

Start: 2015-03-31Target: 150Updated: 2015-08-13

Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects

CompletedNCT02568319

Neothetics, IncCentral Abdominal Bulging

Start: 2015-09-30Target: 120Updated: 2015-12-24

Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat

CompletedNCT03005717

Neothetics, IncSubmental Fat

Start: 2016-12-22End: 2017-06-02Updated: 2017-10-20

Phase 3

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat

CompletedNCT02397499

Neothetics, IncCentral Abdominal Bulging

Start: 2015-04-30Target: 800Updated: 2016-01-08

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

CompletedNCT02398188

Evofem Inc.Central Abdominal Bulging

Start: 2015-04-09End: 2015-10-29Updated: 2019-01-07

Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202

TerminatedNCT02483533

Evofem Inc.Central Abdominal Bulging

Start: 2015-06-30End: 2016-02-26Updated: 2019-12-10